Digestive disease week 2011: highlights of clinical and preclinical research on Barrett's esophagus and associated esophageal adenocarcinoma

Dis Esophagus. 2013 Feb-Mar;26(2):130-40. doi: 10.1111/j.1442-2050.2012.01340.x. Epub 2012 Mar 27.

Abstract

Clinicians and basic researchers worldwide convened at the annual Digestive Disease Week where the latest research in the field of gastroenterology and hepatology is presented. In this report, the highlights of the convention on the field of Barrett's esophagus (BE) and associated esophageal adenocarcinoma (EAC) are summarized. New clinical and preclinical developments in etiology, diagnosis, surveillance, and prevention and therapy of BE and EAC in respect to current knowledge are reflected. We also discuss the relevance and impact of these findings on the future of BE and EAC research.

Publication types

  • Congress

MeSH terms

  • Adenocarcinoma* / diagnosis
  • Adenocarcinoma* / etiology
  • Adenocarcinoma* / metabolism
  • Adenocarcinoma* / therapy
  • Barrett Esophagus* / diagnosis
  • Barrett Esophagus* / etiology
  • Barrett Esophagus* / metabolism
  • Barrett Esophagus* / therapy
  • Biomarkers / metabolism
  • Biopsy
  • Disease Progression
  • Esophageal Neoplasms* / diagnosis
  • Esophageal Neoplasms* / etiology
  • Esophageal Neoplasms* / metabolism
  • Esophageal Neoplasms* / therapy
  • Esophagectomy
  • Esophagoscopy
  • Esophagus / pathology
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Risk Factors

Substances

  • Biomarkers
  • Gastrointestinal Agents